Revelation Biosciences Expands Acute Kidney Injury Advisory Board

June 1, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced the expansion of its Acute Kidney Injury (AKI) Advisory Board, with the addition of two new members, Dr. Peter Pickkers and Dr. Lui Forni, ahead of its upcoming Phase 2/3 clinical trial. The distinguished panel comprises internationally recognized...

Read more

CVS Health: Helping Seniors Navigate Digital-First Health Care

June 1, 2026 9:00 AM

Originally published on CVS Health Company NewsroomKey pointsMany older adults struggle with digital health literacy, making everyday health tasks harder as digital-first care becomes more common.Seniors face real barriers to digital care, but they're eager to learn and want tools and experiences designed with them in mind.CVS Health is already taking meaningful steps to close the digital divide and make care simpler and more accessible for...

Read more

They're Calling It Hemp, Cannabis Medicine. Pesticides, Mycotoxins, Fraudulent Lab Reports? And Medicare Is Now Reimbursing It

June 1, 2026 8:25 AM

Let's start with what medicine actually is. Pesticides. Mycotoxins. Fraudulent Lab Reports. Now Covered by Medicare.Medicine is a substance manufactured under validated, documented, reproducible conditions - conditions that guarantee, to the highest scientifically achievable degree of certainty, that what is in the bottle is what the label says, that nothing else is in the bottle that shouldn't be, and that the patient receiving it is not...

Read more

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

June 1, 2026 8:00 AM

Moderna, Inc. (NASDAQ:MRNA) and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced detailed results from a planned five-year follow-up analysis of the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy (INT), in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients...

Read more

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

June 1, 2026 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Rivaroxaban tablets of 2.5mg, 10mg, 15mg and 20mg for the Canadian market. Rivaroxaban is the generic equivalent of the brand name anticoagulant, Xarelto®.Rivaroxaban is a direct oral anticoagulant prescribed to treat and prevent deep vein...

Read more

Black Book to Release Highly Anticipated 2026 Vendor-Agnostic RCM KPI Results Ahead of HFMA Annual Conference 2026

June 1, 2026 7:50 AM

Black Book Research today announced the upcoming release of its 2026 Vendor-Agnostic Revenue Cycle Management Qualitative KPI Results, a new decision-support framework created for hospitals, health systems, physician enterprises, ambulatory networks, CFOs, revenue cycle executives, CIOs, procurement teams, and managed services buyers evaluating RCM platforms, functional software, automation tools, analytics solutions, and outsourced or...

Read more

Wellgistics Health Provides Mid-Year 2026 Corporate Outlook

June 1, 2026 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today provided a mid-year 2026 corporate outlook. The Company intends to focus on closing the recently announced DelivMeds AI transaction, continuing to drive quarter-over-quarter growth through its Wellgistics Pharmacy business unit, and supporting the...

Read more

Riccio Pharmacy Online Pharmacy Delivery: What Patients Should Know

June 1, 2026 7:30 AM

Healthcare is becoming more digital every year, and online pharmacy delivery services are now playing a major role in how patients manage medications and wellness products. For many people, convenience, accessibility, and reliable service are just as important as the medications themselves.Riccio Pharmacy has expanded its online pharmacy delivery services to help patients receive prescriptions, supplements, and healthcare products more easily...

Read more

Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress

June 1, 2026 7:05 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that four abstracts highlighting rusfertide in polycythemia vera (PV) will be presented at the 2026 European Hematology Association Congress (EHA2026 Congress), taking place June 11-14, 2026, in Stockholm, Sweden. The presentations include analyses from the randomized, controlled Phase 3 VERIFY study, as well as long-term results from the Phase 2 REVIVE and THRIVE...

Read more

VOKA Takes Platinum at the TITAN Health Awards 2026

June 1, 2026 6:05 AM

VOKA, one of the leading medical visualization companies, has been named a Platinum Winner at the TITAN Health Awards 2026. The company topped the "Video, Commercial & Film - Animation" category with its video " Inside Immune System: Granulocytopoiesis Explained in 3D ". This international recognition highlights VOKA's dedication to digital innovation in healthcare through realistic 3D content. It also reinforces the company's focus on...

Read more

Who Does the Best Liposuction in Sarasota?

June 1, 2026 6:00 AM

Liposuction remains one of the most commonly discussed cosmetic surgery procedures for patients seeking to address stubborn fat in areas such as the abdomen, waist, hips, thighs, back, and arms. In Sarasota, determining who performs the best liposuction often comes down to measurable factors including surgical training, body-contouring specialization, patient outcomes, safety standards, procedural experience, and consistency in achieving...

Read more

Who Does the Best Mommy Makeover in Seattle?

June 1, 2026 6:00 AM

Interest in mommy makeover procedures continues to grow as more patients seek surgical solutions for physical changes following pregnancy and weight fluctuations. Patients researching the procedure often evaluate surgeon experience, surgical approach and recovery planning when selecting a provider for mommy makeover. In this case, plastic surgeon Dr. Javad Sajan of Allure Esthetic is frequently referenced in online searches, patient...

Read more

Med-X Secures Strategic Relationship with Main Line Brands, Franchisor of Mosquito Authority and Pest Authority, One of the Largest Pest Control Franchise Systems in North America

June 1, 2026 6:00 AM

Med-X, Inc. ("Med-X" or the "Company") (Nasdaq:MXRX), a leading innovator of all-natural pest control solutions, today announced that it has secured a strategic relationship with Mosquito Authority and Pest Authority, a leader in pest control across North America with over 500 territories spanning 39 states and Canada. Following months of rigorous field testing, Mosquito Authority and Pest Authority has selected the Nature-Cide brand as their...

Read more

Senzime Advances Sustainable Anesthesia Monitoring with Launch of New EMG Sensor

June 1, 2026 5:15 AM

Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced the launch of its latest TetraSens® EMG sensor for use with the TetraGraph® Train-of-Four monitoring system. The new sensor is designed and manufactured with focus on sustainability, performance and usability. It is now commercially available in European markets and will be introduced in the United States during the third quarter of 2026.The new TetraSens design uses 50 percent less dielectric...

Read more

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

June 1, 2026 5:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced an expanded collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance the development of a potential vaccine against Bundibugyo ebolavirus (BDBV), a cause of Ebola virus disease for which there are currently no licensed vaccines indicated.Under the agreement, CEPI has committed up to US $50 million to support preclinical development and Phase 1 clinical testing of...

Read more

GERSTEL Strengthens Global Scientific Engagement with Bioz to Unlock Publication-Driven Insights Across Its Product Portfolio

June 1, 2026 4:00 AM

Bioz, Inc., the platform converting publications into product credibility, announced its collaboration with GERSTEL, is a member of the Velaris family, which includes more than seven brands and is home to some of the world's leading laboratory automation companies, supported by the global investment firm Battery Ventures. GERSTEL is enhancing how researchers discover and engage with publication-backed validation through the implementation of...

Read more

Gen Z Is Transforming Cosmetic Consumption: Science, Safety, and Sustainability Go First

June 1, 2026 3:20 AM

With the world consistently leaning toward more mindful living and forever forward-thinking, health, safety, and the planet are becoming indispensable parts of the equation for consumers. Trending beauty ideals are no longer just about aesthetics, as they have become a reflection of intelligence, intent, and integrity.Gen Z, the demographic that kickstarted this fundamental shift, continues to actively rewrite the rules of how beauty should be...

Read more

Marin and Sonoma County Chiropractor Dr. Sarah Scharf Launches 12-Week Knee Restoration Protocol to Help Active Adults Avoid Surgery

June 1, 2026 2:42 AM

Dr. Sarah Scharf, a chiropractor with two decades of experience treating knee pain across Marin and Sonoma County, has launched a 12-week knee restoration protocol designed to give active adults a serious non-surgical option before they consider an operating room.Delivered through Marin Joint Health, Dr. Scharf's Novato-based clinic, the program is built for patients dealing with arthritis, meniscus tears, ligament injuries, tendonitis, or...

Read more

Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait?

May 31, 2026 1:40 PM

Before a single witness takes the stand at the DEA Hearing Facility on June 29, 2026, there is a haunting figure that must be placed on the record: 2,500 days. That is the approximate number of days the Drug Enforcement Administration-under the deliberate stewardship of former Administrator Anne Milgram and her deputies Thomas Prevoznik, Matthew Strait, Thomas Cook and Aarathi Haig-slow-walked, stonewalled, and bureaucratically suffocated a...

Read more

MMJ ET AL PREPARES APPEAL CMS HEMP PROGRAM: How Can a Company With a Manufactured Pharmaceutical Soft Gel Be Told It Has "No Product"?

May 30, 2026 12:40 PM

One sentence from Judge Trevor McFadden's dismissal of Smart Approaches to Marijuana challenge to CMS's cannabinoid reimbursement program may ultimately become one of the most consequential statements in the entire litigation. The Court concluded that MMJ International Holdings was not a direct competitor in the market and noted that the company had "no product" currently being sold into the Medicare marketplace.Legally, that statement formed...

Read more